Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1961 Sep 9;85(11):631–637.

Spironolactone (Aldactone) Therapy for Ascites due to Cirrhosis of the Liver *

Charles H Lockwood
PMCID: PMC1848287  PMID: 13763007

Full text

PDF
633

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biron P., Koiw E., Nowaczynski W., Brouillet J., Genest J. THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE. J Clin Invest. 1961 Feb;40(2):338–347. doi: 10.1172/JCI104261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bruce H. A. CANCER OF THE STOMACH: WITH SPECIAL REFERENCE TO ITS RELATIONSHIP TO GASTRIC ULCER AND THE ADVANTAGE OF A TWO-STAGE OPERATION. Can Med Assoc J. 1911 Sep;1(9):805–831. [PMC free article] [PubMed] [Google Scholar]
  3. FARRELLY R. O., HOWIE R. N., NORTH J. D. Use of spironolactone and hydrochlorothiazide in treatment of oedema. Br Med J. 1960 Jul 30;2(5195):339–343. doi: 10.1136/bmj.2.5195.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GABUZDA G. J., Jr, DAVIDSON C. S. Protein metabolism in patients with cirrhosis of the liver. Ann N Y Acad Sci. 1954 May 10;57(6):776–785. doi: 10.1111/j.1749-6632.1954.tb36454.x. [DOI] [PubMed] [Google Scholar]
  5. GENEST J. Angiotensin, aldosterone and human arterial hypertension. Can Med Assoc J. 1961 Feb 25;84:403–419. [PMC free article] [PubMed] [Google Scholar]
  6. HENLEY K. S., STREETEN D. H., POLLARD H. M. Hyperaldo-steronism in liver disease. The treatment of refractory ascites by adrenalectomy and by the administration of spirolactones. Gastroenterology. 1960 May;38:681–689. [PubMed] [Google Scholar]
  7. ONEN K. H. Renal haemodynamics in hepatic cirrhosis. Lancet. 1960 Jan 23;1(7117):203–204. doi: 10.1016/s0140-6736(60)90116-1. [DOI] [PubMed] [Google Scholar]
  8. PITTS R. F. Some reflections on mechanisms of action of diuretics. Am J Med. 1958 May;24(5):745–763. doi: 10.1016/0002-9343(58)90378-4. [DOI] [PubMed] [Google Scholar]
  9. READ A. E., LAIDLAW J., HASLAM R. M., SHERLOCK S. Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: possible relation to hypokalaemia. Clin Sci. 1959 Aug;18:409–423. [PubMed] [Google Scholar]
  10. SHALDON S., McLAREN J. R., SHERLOCK S. Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide). Lancet. 1960 Mar 19;1(7125):609–613. doi: 10.1016/s0140-6736(60)90500-6. [DOI] [PubMed] [Google Scholar]
  11. SHERLOCK S. Pathogenesis and management of hepatic coma. Am J Med. 1958 May;24(5):805–813. doi: 10.1016/0002-9343(58)90382-6. [DOI] [PubMed] [Google Scholar]
  12. TYOR M. P., SIEKER H. O. Biochemical, blood gas and peripheral circulatory alterations in hepatic coma. Am J Med. 1959 Jul;27(1):50–59. doi: 10.1016/0002-9343(59)90060-9. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES